ABCL - AbCellera Biologics Inc.

3.45
-0.140   -4.058%

Share volume: 4,246,409
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.26%

PREVIOUS CLOSE
CHG
CHG%
$3.59
-0.14
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 05-07-2024 08-06-2024 11-04-2024 02-27-2025 05-08-2025 11-06-2025 02-24-2026
Total revenue 9.954 M 7.323 M 6.507 M 5.049 M 4.235 M 8.955 M 44.854 M
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 9.954 M 7.323 M 6.507 M 5.049 M 4.235 M 8.955 M 44.854 M
    -26.43% -11.14% -22.41% -16.12% 111.45% 400.88%  
Operating expenses 56.639 M 61.119 M 60.116 M 62.096 M 58.722 M 77.080 M 76.068 M
Selling general and admin 17.352 M 20.192 M 19.147 M 16.020 M 16.226 M 22.052 M 25.976 M
Research and development 39.287 M 40.927 M 40.969 M 46.076 M 42.496 M 55.028 M 50.092 M
Total expenses 64.848 M 100.777 M 100.170 M 77.804 M 66.895 M 85.233 M 73.434 M
    55.40% -0.60% -22.33% -14.02% 27.41% -13.84%  
Operating income -54.894 M -93.454 M -93.663 M -72.755 M -62.660 M -76.278 M -28.580 M
Ebit -53.148 M -57.988 M -72.235 M -55.497 M -61.035 M -75.533 M -25.420 M
Pretax income -42.747 M -48.187 M -62.632 M -46.829 M -52.984 M -68.768 M -19.499 M
    12.73% 29.98% -25.23% 13.14% 29.79% -71.65%  
Income tax -2.137 M -11.257 M -11.525 M -12.619 M -7.363 M -11.649 M -10.554 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -40.610 M -36.930 M -51.107 M -34.210 M -45.621 M -57.119 M -8.945 M
    9.06% -38.39% 33.06% -33.36% -25.20% 84.34%